Epidemiology of compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights from NHANES 2017-2020

IF 11.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Clinical Gastroenterology and Hepatology Pub Date : 2025-06-26 DOI:10.1016/j.cgh.2025.06.010

Ritik M. Goyal MD, Apoorva Doshi MD, Sameer Rao MD, Komal Arora MD, Supriya Maheshwari MD, Paul Gaglio MD

引用次数: 0

Abstract

Compensated Advanced Chronic Liver Disease (cACLD) encompasses advanced fibrosis and cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension (CSPH). Patients having cACLD are at high risk of decompensation and liver-related mortality, hence require further evaluation. Due to limited epidemiological data on cACLD, we aimed to assess its prevalence in the US.

查看原文本刊更多论文

代偿性晚期慢性肝病（cACLD）在美国的流行病学：来自NHANES 2017-2020的见解

代偿性晚期慢性肝病（cACLD）包括无症状患者的晚期纤维化和肝硬化，有发展为临床显著门脉高压（CSPH）的风险。cACLD患者处于失代偿和肝脏相关死亡的高风险，因此需要进一步评估。由于cld的流行病学资料有限，我们的目的是评估其在美国的患病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Gastroenterology and Hepatology 医学-胃肠肝病学

CiteScore

16.90

自引率

4.80%

发文量

903

审稿时长

22 days

期刊介绍： Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.